Riyadh – Mubasher: Al Hammadi Holding Company achieved net profits amounting to SAR 71.89 million for the second quarter (Q2) of 2026, an annual rise of 16.03% from SAR 61.96 million.
The healthcare provider’s quarterly revenue climbed by 7.88% to SAR 321.75 million, supported by a 24.4% growth in the pharmaceutical products segment and a 3.9% increase in medical services.
The bottom-line growth was further bolstered by the reversal of SAR 9.17 million in expected credit loss provisions following improved collection rates from major clients.
Additionally, the company recorded a SAR 6.99 million gain from the disposal of property in Riyadh’s Al Mounisiyah district. Share of profit from associates also jumped by 108.13% to SAR 14.69 million.
For the first six months (6M) of 2026, net profit retreated by 5.71% to SAR 128.13 million compared to SAR 135.89 million in the prior-year period.
The half-year decline was attributed to lower gross profit margins, which fell to 28.20% from 31.60% due to rising operating costs and a SAR 16.62 million increase in marketing expenses related to a new brand identity launch.
Earnings per share (EPS) for the six-month period hit SAR 0.80.
At the end of March 2026, the group’s net profits attributable to the shareholders fell by 23.92% to SAR 56.24 million from SAR 73.93 million a year earlier.
